| Authors: |
Law ZK; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK.; Department of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia., Dineen R; Radiological Sciences, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK., England TJ; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK.; Vascular Medicine, Division of Medical Sciences and GEM, University of Nottingham, Nottingham, UK., Cala L; School of Medicine, University of Western Australia, Perth, Australia., Mistri AK; Stroke Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK., Appleton JP; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK., Ozturk S; Department of Neurology, Selcuk University Medical Faculty, Konya, Turkey., Bereczki D; Department of Neurology, Semmelweis University, Budapest, Hungary., Ciccone A; Neurology Unit, Azienda Socio Sanitaria Territoriale di Mantova, Mantua, Italy., Bath PM; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK.; Department of Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Sprigg N; Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, City Hospital, Nottingham, NG5 1PB, UK. nikola.sprigg@nottingham.ac.uk.; Department of Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK. nikola.sprigg@nottingham.ac.uk. |